NEW MULTIPLE SCLEROSIS STUDY OFFERS NEW HOPE TO ...

New Multiple Sclerosis Study Offers New Hope to Those with MS

Dr. Rhonda Voskuhl and her UCLA colleagues seek women for a new clinical trial.

By Amy Sommer??|??April 16, 2013

Dr. Rhonda Voskuhl, Director, Multiple Sclerosis Program

Multiple Sclerosis, (MS) is a chronic inflammatory disease of the central nervous system that affects the brain?s ability to send and receive signals thus compromising its patients? balance, memory, vision and other functions. Researchers have long known that pregnancy affords female MS patients a precipitous drop in symptoms during the last half of gestation.

Could this benefit be extended to people who are not pregnant? Researchers are working to find out if this is possible ? and readers who have MS can help.

In 2003 Dr. Rhonda Voskuhl, director of UCLA's Multiple Sclerosis Program, and her colleagues, conducted a pilot study in which 10 non-pregnant women with MS were given estriol, a hormone produced by the placenta throughout pregnancy. The study participants enjoyed an 80 percent drop in inflammatory lesions in the brain, a telltale sign of the disease. Estriol is a pill that has been available for decades and is often used by menopausal women to lessen their symptoms.

There is also evidence that estrogens may be beneficial for cognition. Approximately half of all MS patients experience cognitive problems such as processing information gathered by one?s senses, attention, concentration and executive functions such as prioritizing tasks. Thus, Voskuhl and her colleagues are expanding the pilot study with a new ongoing trial to determine whether estriol treatment can improve cognition in women with MS. If you are female, between the ages of 18-50 and have the diagnosis of MS, you may qualify to participate in the study. Patients continue to take their standard disease modifying treatment for MS, while adding on treatment with either an estriol or placebo pill.

For more information about the trial, please contact the UCLA MS program at (310) 825-7313.

Comments to date: 3. Page 1 of 1. Average Rating: Claire Bungay??? PEI Canada 8:49am on Wednesday, April 17th, 2013? Good news, keep it coming! I know one of these days we will have an answer. How do you sign up? Admin: ?Thank you for reading this piece. For more information about the trial, please contact the UCLA MS program at (310) 825-7313. Kathy McGlothlin??? Owensboro, KY 5:42am on Wednesday, April 17th, 2013? I think it's a fantastic idea! I hope I get to participate in the study! I am 49, was diagnosed in 2002 and had a full hysterectomy in 2006. I began HRT about 6 months after my surgery. I stopped taking HRT about 1? yrs ago. I have had a noticeable increase in cognitive and physical difficulties since then. To the point my neurologist had an EEG done; it showed "significant reduction in brain activity". I don't know if I can return to my former functioning level, but if it can at least slow the progression that would be a blessing. It's wonderful that there is always hope! Admin: ?Please consider enrolling in the UCLA trial. For more information about it, call (310) 825-7313. Sarah Rainbolt??? Canada 2:23pm on Tuesday, April 16th, 2013? It's BS my MS began in pregnancy and my second put me in a chair so stop selling this idea it can be dangerous! Admin: ?I'm sorry to hear that your experience with pregnancy was negative. I hope that you find some relief for your symptoms.

Source: http://www.westsidetoday.com/s12-9317/new-multiple-sclerosis-study.html

go daddy Tom Kenny Long Island Medium Alfonso Ribeiro adam sandler College Football Scoreboard nfl scores